Clinical trial
Olanzapine Augmentation Therapy in Treatment-resistant Depression: a…
NCT00273624 · University Hospital Freiburg, Other · Withdrawn
Key facts
| NCT number | NCT00273624 |
|---|---|
| Title | Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial |
| Official title | Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial |
| Lead sponsor | University Hospital Freiburg, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Therapy-resistant Depression |
| Intervention type | Drug |
| Interventions | Olanzapine, Placebo |
| Enrollment | 0 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 10, 2022 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: